These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 37854371)

  • 21. Two or more dexamethasone intravitreal implants in treatment-naïve patients with macular edema due to retinal vein occlusion: subgroup analysis of a retrospective chart review study.
    Dugel PU; Capone A; Singer MA; Dreyer RF; Dodwell DG; Roth DB; Shi R; Walt JG; Scott LC; Hollander DA;
    BMC Ophthalmol; 2015 Sep; 15():118. PubMed ID: 26337664
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Two-year, prospective, multicenter study of the use of dexamethasone intravitreal implant for treatment of macular edema secondary to retinal vein occlusion in the clinical setting in France.
    Korobelnik JF; Kodjikian L; Delcourt C; Gualino V; Leaback R; Pinchinat S; Velard ME
    Graefes Arch Clin Exp Ophthalmol; 2016 Dec; 254(12):2307-2318. PubMed ID: 27286894
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Twenty-Four Month Results of Intravitreal Ranibizumab for Macular Edema after Branch Retinal Vein Occlusion: Visual Outcomes and Resolution of Macular Edema.
    Inagaki M; Hirano Y; Yasuda Y; Kawamura M; Suzuki N; Yasukawa T; Yoshida M; Ogura Y
    Semin Ophthalmol; 2021 Oct; 36(7):482-489. PubMed ID: 33617388
    [No Abstract]   [Full Text] [Related]  

  • 24. Predictive factors for functional improvement after intravitreal bevacizumab therapy for macular edema due to branch retinal vein occlusion.
    Jaissle GB; Szurman P; Feltgen N; Spitzer B; Pielen A; Rehak M; Spital G; Heimann H; Meyer CH;
    Graefes Arch Clin Exp Ophthalmol; 2011 Feb; 249(2):183-92. PubMed ID: 21337042
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti-Vascular Endothelial Growth Factor Therapy for Macular Edema following Central Retinal Vein Occlusion: 1 Initial Injection versus 3 Monthly Injections.
    Osaka R; Muraoka Y; Miwa Y; Manabe K; Kobayashi M; Takasago Y; Ooto S; Murakami T; Suzuma K; Iida Y; Tsujikawa A
    Ophthalmologica; 2018; 239(1):27-35. PubMed ID: 28946138
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison between Ozurdex and intravitreal anti-vascular endothelial growth factor treatment for retinal vein occlusion-related macular edema: A systematic review and meta-analysis of randomized controlled trials.
    Hu Q; Li H; Xu W; Du Y; Ma C; He J
    Indian J Ophthalmol; 2019 Nov; 67(11):1800-1809. PubMed ID: 31638037
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of dexamethasone intravitreal implant with intravitreal anti-VEGF injections for the treatment of macular edema secondary to branch retinal vein occlusion: A meta-analysis.
    Ji K; Zhang Q; Tian M; Xing Y
    Medicine (Baltimore); 2019 May; 98(22):e15798. PubMed ID: 31145307
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Optical coherence tomography findings as a predictor of clinical course in patients with branch retinal vein occlusion treated with ranibizumab.
    Shiono A; Kogo J; Sasaki H; Yomoda R; Jujo T; Tokuda N; Kitaoka Y; Takagi H
    PLoS One; 2018; 13(6):e0199552. PubMed ID: 29924853
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intravitreal PRN ranibizumab treatment for macular edemadue to branch retinal vein occlusion.
    Çakmak HB; Arikan Yorgun M; Toklu Y; Mutlu M
    Turk J Med Sci; 2017 Feb; 47(1):40-46. PubMed ID: 28263518
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anti-vascular endothelial growth factor for macular oedema secondary to branch retinal vein occlusion.
    Shalchi Z; Mahroo O; Bunce C; Mitry D
    Cochrane Database Syst Rev; 2020 Jul; 7(7):CD009510. PubMed ID: 32633861
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term clinical effects of intravitreal injections of conbercept for the treatment of choroidal neovascularization in patients with pathological myopia.
    Zhang S; He ZF; Chen FF; Zhang WW; Liu YJ; Chen H; Xie ZG
    Int J Ophthalmol; 2022; 15(12):1971-1977. PubMed ID: 36536971
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anti-vascular endothelial growth factor for macular oedema secondary to central retinal vein occlusion.
    Braithwaite T; Nanji AA; Lindsley K; Greenberg PB
    Cochrane Database Syst Rev; 2014 May; 2014(5):CD007325. PubMed ID: 24788977
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion.
    Haller JA; Bandello F; Belfort R; Blumenkranz MS; Gillies M; Heier J; Loewenstein A; Yoon YH; Jacques ML; Jiao J; Li XY; Whitcup SM;
    Ophthalmology; 2010 Jun; 117(6):1134-1146.e3. PubMed ID: 20417567
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of Multiple Dexamethasone Intravitreal Implants for Refractory Retinal Vein Occlusion-Related Macular Edema and Effect of Prior Vitrectomy.
    Houben I; De Zaeytijd J; Deghislage C; Frost NA; Nijs I; Van Calster J
    J Ocul Pharmacol Ther; 2018 Dec; 34(10):710-719. PubMed ID: 30403557
    [No Abstract]   [Full Text] [Related]  

  • 35. Three Monthly Injections Versus One Initial Injection of Ranibizumab for the Treatment of Macular Edema Secondary to Branch Retinal Vein Occlusion: 12-Month Results of a Prospective Randomized Study.
    Tang W; Guo J; Xu G; Liu W; Chang Q
    Ophthalmol Ther; 2022 Dec; 11(6):2309-2320. PubMed ID: 36223056
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bevacizumab versus bevacizumab and macular grid photocoagulation for macular edema in eyes with non-ischemic branch retinal vein occlusion: results from a prospective randomized study.
    Callizo J; Atili A; Striebe NA; Bemme S; Feltgen N; Hoerauf H; Bertelmann T
    Graefes Arch Clin Exp Ophthalmol; 2019 May; 257(5):913-920. PubMed ID: 30610424
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The outcome of low-frequency intravitreal bevacizumab therapy for macular edema in retinal vein occlusions.
    Ivanovska Adjievska B; Boskurt S; Orovcanec N; Dimovska-Jordanova V
    Clin Ophthalmol; 2017; 11():1183-1190. PubMed ID: 28790803
    [TBL] [Abstract][Full Text] [Related]  

  • 38. One-year efficacy of intravitreal conbercept injection for macular oedema secondary to central retinal vein occlusion in Chinese patients.
    Zeng HY; Liu Q; Li XX; Sun YX; Zhang ZJ
    Eye (Lond); 2020 Aug; 34(8):1459-1464. PubMed ID: 32094473
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dexamethasone intravitreal implant in retinal vein occlusion: real-life data from a prospective, multicenter clinical trial.
    Eter N; Mohr A; Wachtlin J; Feltgen N; Shirlaw A; Leaback R;
    Graefes Arch Clin Exp Ophthalmol; 2017 Jan; 255(1):77-87. PubMed ID: 27460280
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The influence of anti-VEGF therapy on present day management of macular edema due to BRVO and CRVO: a longitudinal analysis on visual function, injection time interval and complications.
    Papadia M; Misteli M; Jeannin B; Herbort CP
    Int Ophthalmol; 2014 Dec; 34(6):1193-201. PubMed ID: 25245600
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.